All stocks today
71229 stocks real-time data.
All stocks today

Stock quotes

Stock market live

Historical stock prices

Stocks market capitalization

Dividend stocks

Stock earnings

Stock revenue

Stock ratings. Where to invest?

Blonder Tongue Laboratories, Inc. revenue reports

Blonder Tongue Laboratories, Inc. financial reports, Blonder Tongue Laboratories, Inc. annual revenue in 2024. When does Blonder Tongue Laboratories, Inc. report revenue?
Add to widgets
Added to widgets

Blonder Tongue Laboratories, Inc. total revenue, net income and dynamics of changes in US dollar today

Net revenue of Blonder Tongue Laboratories, Inc. on 31/03/2021 amounted to 3 251 000 $. The dynamics of Blonder Tongue Laboratories, Inc. net revenue decreased by -1 076 000 $ from the last reporting period. These are the main financial indicators of Blonder Tongue Laboratories, Inc.. Blonder Tongue Laboratories, Inc. online financial report chart. The financial report chart on our website displays information by dates from 30/06/2017 to 31/03/2021. Blonder Tongue Laboratories, Inc. financial report on the graph shows the dynamics of assets.

Report date Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
and Change (%)
Comparing current quartal report this year to quartal report last year.
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
and Change (%)
Comparing current quartal report this year to quartal report last year.
31/03/2021 3 251 000 $ -20.358 % ↓ -414 000 $ -107.775 % ↓
31/12/2020 4 327 000 $ -20.474 % ↓ -2 413 000 $ -
30/09/2020 4 171 000 $ -20.974 % ↓ -1 787 000 $ -
30/06/2020 3 831 000 $ -29.538 % ↓ -1 194 000 $ -
30/09/2019 5 278 000 $ - -1 334 000 $ -
30/06/2019 5 437 000 $ - -891 000 $ -
31/03/2019 4 082 000 $ - 5 325 000 $ -
31/12/2018 5 441 000 $ - -742 000 $ -
30/09/2018 5 626 000 $ - -199 000 $ -
30/06/2018 5 277 000 $ - -335 000 $ -
31/03/2018 5 363 000 $ - -63 000 $ -
31/12/2017 5 570 000 $ - 256 000 $ -
30/09/2017 5 576 000 $ - -153 000 $ -
30/06/2017 6 164 000 $ - -231 000 $ -
Show:
to

Blonder Tongue Laboratories, Inc. financial report charts

The dates of the latest financial statements of Blonder Tongue Laboratories, Inc.: 30/06/2017, 31/12/2020, 31/03/2021. The dates of financial statements are strictly regulated by law and financial statements. The current date of the financial report of Blonder Tongue Laboratories, Inc. for today is 31/03/2021. Gross profit Blonder Tongue Laboratories, Inc. is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services. Gross profit Blonder Tongue Laboratories, Inc. is 1 385 000 $

Blonder Tongue Laboratories, Inc. quarterly report dates

Cost of revenue Blonder Tongue Laboratories, Inc. is the total cost of producing and distributing of products and services of a company. Cost of revenue Blonder Tongue Laboratories, Inc. is 1 866 000 $ Total revenue Blonder Tongue Laboratories, Inc. refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods. Total revenue Blonder Tongue Laboratories, Inc. is 3 251 000 $ Operating income Blonder Tongue Laboratories, Inc. is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS). Operating income Blonder Tongue Laboratories, Inc. is -863 000 $

Net income Blonder Tongue Laboratories, Inc. is an entity's income minus cost of goods sold, expenses and taxes for an accounting period. Net income Blonder Tongue Laboratories, Inc. is -414 000 $ Current assets Blonder Tongue Laboratories, Inc. is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year. Current assets Blonder Tongue Laboratories, Inc. is 6 358 000 $ Total assets Blonder Tongue Laboratories, Inc. refers to the total amount of assets owned by a person or entity. Total assets Blonder Tongue Laboratories, Inc. is 11 123 000 $

31/03/2021 31/12/2020 30/09/2020 30/06/2020 30/09/2019 30/06/2019 31/03/2019 31/12/2018 30/09/2018 30/06/2018 31/03/2018 31/12/2017 30/09/2017 30/06/2017
Gross profit
Gross profit is the profit a company makes after deducting the costs of making and selling its products, or the costs of providing its services.
1 385 000 $ 495 000 $ 735 000 $ 1 235 000 $ 1 531 000 $ 2 005 000 $ 1 091 000 $ 1 592 000 $ 2 413 000 $ 2 191 000 $ 2 223 000 $ 2 233 000 $ 2 177 000 $ 2 125 000 $
Cost of revenue
Cost of revenue is the total cost of producing and distributing of products and services of a company.
1 866 000 $ 3 832 000 $ 3 436 000 $ 2 596 000 $ 3 747 000 $ 3 432 000 $ 2 991 000 $ 3 849 000 $ 3 213 000 $ 3 086 000 $ 3 140 000 $ 3 337 000 $ 3 399 000 $ 4 039 000 $
Total revenue
Total revenue refers to the total receipts from sales of a given quantity of goods or services. It is the total income of a business and is calculated by multiplying the quantity of goods sold by the price of the goods.
3 251 000 $ 4 327 000 $ 4 171 000 $ 3 831 000 $ 5 278 000 $ 5 437 000 $ 4 082 000 $ 5 441 000 $ 5 626 000 $ 5 277 000 $ 5 363 000 $ 5 570 000 $ 5 576 000 $ 6 164 000 $
Operating revenue
Operating revenue is revenue generated from a company's primary business activities. For example, a retailer produces revenue through merchandise sales, and a physician derives revenue from the medical services he/she provides.
- - - - 5 278 000 $ 5 437 000 $ 4 082 000 $ 5 441 000 $ 5 626 000 $ 5 277 000 $ 5 363 000 $ 5 570 000 $ 5 576 000 $ 6 164 000 $
Operating income
Operating income is an accounting figure that measures the amount of profit realized from a business's operations, after deducting operating expenses such as wages, depreciation and cost of goods sold (COGS).
-863 000 $ -2 305 000 $ -1 682 000 $ -1 108 000 $ -1 283 000 $ -845 000 $ -1 767 000 $ -680 000 $ -44 000 $ -217 000 $ 87 000 $ 380 000 $ -15 000 $ -138 000 $
Net income
Net income is an entity's income minus cost of goods sold, expenses and taxes for an accounting period.
-414 000 $ -2 413 000 $ -1 787 000 $ -1 194 000 $ -1 334 000 $ -891 000 $ 5 325 000 $ -742 000 $ -199 000 $ -335 000 $ -63 000 $ 256 000 $ -153 000 $ -231 000 $
R&D spending
Research and Development spending - cost of investigative activities to improve existing products and procedures or to lead to the development of new products and procedures.
638 000 $ 659 000 $ 600 000 $ 608 000 $ 848 000 $ 778 000 $ 665 000 $ 604 000 $ 672 000 $ 643 000 $ 657 000 $ 575 000 $ 605 000 $ 644 000 $
Operating expense
An operating expense is an expenditure that a business incurs as a result of performing its normal business operations.
4 114 000 $ 6 632 000 $ 5 853 000 $ 4 939 000 $ 6 561 000 $ 6 282 000 $ 5 849 000 $ 6 121 000 $ 5 670 000 $ 5 494 000 $ 2 136 000 $ 1 853 000 $ 2 192 000 $ 2 263 000 $
Current assets
Current assets is a balance sheet item that represents the value of all assets that can reasonably expect to be converted into cash within one year.
6 358 000 $ 6 104 000 $ 8 201 000 $ 10 947 000 $ 12 079 000 $ 12 295 000 $ 11 503 000 $ 10 377 000 $ 9 547 000 $ 8 829 000 $ 9 219 000 $ 8 950 000 $ 8 803 000 $ 8 274 000 $
Total assets
Total assets refers to the total amount of assets owned by a person or entity.
11 123 000 $ 11 130 000 $ 13 536 000 $ 16 625 000 $ 18 503 000 $ 18 786 000 $ 18 143 000 $ 15 601 000 $ 15 378 000 $ 14 719 000 $ 15 235 000 $ 15 174 000 $ 15 179 000 $ 14 714 000 $
Current cash
Current cash - the sum of all of the cash a company has on the date of report.
56 000 $ 69 000 $ 75 000 $ 465 000 $ 369 000 $ 212 000 $ 1 628 000 $ 559 000 $ 96 000 $ 444 000 $ 238 000 $ 168 000 $ 199 000 $ 361 000 $
Current debt
Current debt is the portion of debt due within a year (12 months) and is listed as a current liability and part of net working capital.
- - - - 4 667 000 $ 3 682 000 $ 2 175 000 $ 8 263 000 $ 4 678 000 $ 3 939 000 $ 2 381 000 $ 2 736 000 $ 2 677 000 $ 2 218 000 $
Total cash
Total cash - the sum of all of the cash a company has on its books, including petty cash and funds on deposit in a bank.
- - - - - - - - - - 238 000 $ 168 000 $ 199 000 $ 361 000 $
Total debt
Total debt is a combination of both short-term and long-term debt. Short-term debts are those that must be paid back within a year. Long-term debt generally includes every liability that must be paid off in more than a year.
- - - - 7 486 000 $ 6 666 000 $ 5 362 000 $ 8 434 000 $ 7 697 000 $ 7 018 000 $ 6 060 000 $ 6 454 000 $ 6 439 000 $ 6 016 000 $
Debt ratio
Total debt to total assets - is a financial ratio that indicates the percentage of a company's assets that are provided via debt.
- - - - 40.46 % 35.48 % 29.55 % 54.06 % 50.05 % 47.68 % 39.78 % 42.53 % 42.42 % 40.89 %
Shareholders equity
Shareholder's equity (SE) is the owner's claim after subtracting total liabilities from total assets.
1 505 000 $ 1 237 000 $ 2 614 000 $ 4 300 000 $ 11 017 000 $ 12 120 000 $ 12 781 000 $ 7 167 000 $ 7 681 000 $ 7 701 000 $ 7 434 000 $ 7 413 000 $ 6 588 000 $ 6 601 000 $
Cash flow
Cash flow is the net amount of cash and cash-equivalents being transferred into and out of a business.
- - - - -628 000 $ -1 351 000 $ -3 024 000 $ 491 000 $ -1 223 000 $ 814 000 $ 505 000 $ 13 000 $ -466 000 $ -20 000 $

Last revenue report of Blonder Tongue Laboratories, Inc. was 31/03/2021. According to last financial report total revenue in Blonder Tongue Laboratories, Inc. was 3 251 000 US dollar and changed by -20.358% since last year. Net income in Blonder Tongue Laboratories, Inc. was -414 000 $ in last quartal, net income changes to -107.775%.

Current cash Blonder Tongue Laboratories, Inc. - the sum of all of the cash a company has on the date of report. Current cash Blonder Tongue Laboratories, Inc. is 56 000 $

Blonder Tongue Laboratories, Inc. stocks data

Blonder Tongue Laboratories, Inc. financials